Issue Date | Title | Author(s) |
2023 | Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China | Hua, Rui; Kong, Fei; Li, Guangming; Wen, Xiaofeng; Zhang, Yuexin; Yang, Xingxiang; Meng, Chenxin; Xie, Wen; Jiang, Yongfang; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Mao, Qing; Wang, Jiefei; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Xiong, Qingfang; Ma, Hong; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Zhu, Liying; Mao, Xiaorong; Lian, Jianqi; Deng, Guojiong; Xin, Yongning; Wang, Yifei; Ye, Yinong; Xu, Bin; Gao, Hainv; Tan, Youwen; Li, Dongliang; Yang, Dongliang; Su, Minghua; Zhang, Xiaomeng; Min, Jie; Shi, Xinsheng; Wei, Lai; Niu, Junqi |
2019 | All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china | Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
Jul-2020 | Efficacy and Safety of All-oral Emitasvir and Sofosbuvir in Patients with Genotype 1b HCV Infections without Cirrhosis | Rao, Huiying; Yang, Xingxiang; Tan, Youwen; Ning, Qin; Yang, Daokun; Wang, Jiefei; Yang, Yongfeng; Zheng, Sujun; Yang, Dongliang; Hou, Jinlin; Xie, Qing; Zhao, Caiyan; Zhang, Lunli; Mao, Xiaorong; Sun, Tong; Bai, Lang; Zhang, Fuchun; Jin, Jinglan; Zhao, Yingren; Wang, Maorong; Xie, Wen; Ma, Yingjie; Quan, Jun; Yan, Xuebing; An, Ping; Lin, Feng; Jia, Jidong; Hu, Xiaoxuan; Gong, Zuojiong; Wu, Jie; Chen, Yongping; Jia, Zhansheng; Lin, Minghua; Wang, Guiqiang; Zhu, Yueyong; Zhang, Yingjun; Xie, Hongming; Luo, Lin; Ren, Qingyun; Huang, Rui; Wei, Lai |
2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
2018 | Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, FuSheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei |
2019 | Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naive Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China | Xu, Xiaoyuan; Feng, Bo; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; Anl, Ping; Gong, Guozhong; Liu, Huimin; Nine, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Jidong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojiong; Zhang, Quan; Hu, Peng; Wang, Fusheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi J.; Wei, Lai |
Mar-2025 | Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial | Zhang, Mingyuan; Gao, Yanhang; Kong, Fei; Gao, Haibing; Yi, Yongxiang; Wu, Chao; Xin, Yongning; Zheng, Sujun; Lu, Jiajie; Han, Tao; Zhao, Yingren; Hu, Peng; Mao, Xiaorong; Xie, Qing; Zhang, Jie; Hou, Jinlin; Gao, Zhiliang; Lian, Jianqi; Chen, Liang; Shang, Jia; Xie, Wen; Mu, Mao; Jin, Zhenjing; Wang, Maorong; Lin, Shide; Rao, Huiying; Yang, Dongliang; Gong, Huanyu; Luo, Lin; Chen, Yunfu; Zhuang, Yulei; Zhang, Yingjun; Gish, Robert G.; Tan, Youwen; Zhang, Jiming; Niu, Junqi |
2019 | Incidence and Etiology of Drug-Induced Liver Injury in Mainland China | Shen, Tao; Liu, Yingxia; Shang, Jia; Xie, Qing; Li, Jun; Yan, Ming; Xu, Jianming; Niu, Junqi; Liu, Jiajun; Watkins, Paul B.; Aithal, Guruprasad P.; Andrade, Raul J.; Dou, Xiaoguang; Yao, Lvfeng; Lv, Fangfang; Wang, Qi; Li, Yongguo; Zhou, Xinmin; Zhang, Yuexin; Zong, Peilan; Wan, Bin; Zou, Zhengsheng; Yang, Dongliang; Nie, Yuqiang; Li, Dongliang; Wang, Yuya; Han, Xi'an; Zhuang, Hui; Mao, Yimin; Chen, Chengwei |
2013 | Liver Sinusoidal Endothelial Cell Lectin Inhibits CTL-Dependent Virus Clearance in Mouse Models of Viral Hepatitis | Liu, Biao; Wang, Min; Wang, Xiaowen; Zhao, Dianyuan; Liu, Di; Liu, Jing; Chen, Pei-Jer; Yang, Dongliang; He, Fuchu; Tang, Li |
Jul-2021 | SH229 plus daclatasvir for treatment of chronic hepatitis C virus infection in China: a single-arm, open-label, phase 3 study | Hua, Rui; Kong, Fei; Wen, Xiaofeng; Yang, Xingxiang; Meng, Chenxin; Jiang, Yongfang; Xie, Wen; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Wang, Jiefei; Mao, Qing; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Ma, Hong; Xiong, Qingfang; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Mao, Xiaorong; Lian, Jianqi; Zhu, Liying; Xin, Yongning; Deng, Guojiong; Wang, Yifei; Xu, Bin; Gao, Hainv; Tan, Youwen; Ye, Yinong; Li, Dongliang; Yang, Dongliang; Su, Minghua; Li, Cheng; Shen, Xian; Wu, Qiong; Zhang, Xian; Wang, Zhiqiang; Zhao, Liwen; Zhang, Yuexin; Li, Guangming; Niu, Junqi |
2016 | Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naive patients in China and South Korea | Wei, Lai; Han, Tao; Yang, Dongliang; Heo, Jeong; Shang, Jia; Cheng, Jun; Chen, Xinyue; Xie, Qing; Kim, Ju-Hyun; Kalmeijer, Ronald; Ouwerkerk-Mahadevan, Sivi; Hoeben, Eva; Lenz, Oliver; Verbinnen, Thierry; Sinha, Rekha; Li, MengChun; Scott, Jane; Peeters, Monika; Witek, James |
2019 | Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China | Sun, Jian; Ding, Huiguo; Chen, Guofeng; Wang, Guiqiang; Wei, Lai; Zhang, Jiming; Xie, Qing; Wan, Mobin; Tang, Hong; Chen, Shijun; Gao, Zhiliang; Wang, Yuming; Zhang, Dazhi; Huang, Wenxiang; Sheng, Jifang; Ning, Qin; Yang, Dongliang; Lu, Jian; Pan, Chen; Yang, Yuxiu; Wang, Jue; Sun, Chuanzhen; Wang, Qixin; Hou, Jinlin |
2011 | An Unenumerative DNA Computing Model for Vertex Coloring Problem | Xu, Jin; Qiang, Xiaoli; Yang, Yan; Wang, Baoju; Yang, Dongliang; Luo, Liang; Pan, Linqiang; Wang, Shudong |
2018 | Yimitasvir and Sofosbuvir for HCV Genotype 1 Infection | Luo, Bi-Fen; Jin, Jinglan; Rao, Huiying; Ning, Qin; Hou, Jinlin; Bai, Lang; Yang, Yongfeng; Zheng, Sujun; Mao, Xiaorong; Quan, Jun; Yang, Dongliang; Zhang, Lunli; Zhao, Caiyan; Jia, Zhansheng; Zhang, Fuchun; Gong, Zuojiong; Lin, Feng; Wang, Guiqiang; Jin, Qian; Ma, Danli; Luo, Lin; Deng, Li; Xie, Hongming; Jing, Li; Zhang, Yingjun; Wei, Lai |
2018 | Yimitasvir and Sofosbuvir for HCV Genotype 1 Infection | Luo, Bi-Fen; Jin, Jinglan; Rao, Huiying; Ning, Qin; Hou, Jinlin; Bai, Lang; Yang, Yongfeng; Zheng, Sujun; Mao, Xiaorong; Quan, Jun; Yang, Dongliang; Zhang, Lunli; Zhao, Caiyan; Jia, Zhansheng; Zhang, Fuchun; Gong, Zuojiong; Lin, Feng; Wang, Guiqiang; Jin, Qian; Ma, Danli; Luo, Lin; Deng, Li; Xie, Hongming; Jing, Li; Zhang, Yingjun; Wei, Lai |